[ Price : $8.95]
FDA accepts for review an Abeona Therapeutics BLA resubmission for prademagene zamikeracel (pz-cel), a gene therapy for patients w...[ Price : $8.95]
Federal Register notice: FDA determines that Nuplazid (pimavanserin tartrate) tablet (equivalent 17 mg base) was not withdrawn due...[ Price : $8.95]
Federal Register notice: FDA announces a 12/12 public workshop titled Optimizing the Use of Real-World Evidence in Regulatory Deci...[ Price : $8.95]
House Energy and Commerce Committee Republicans ask for a GAO review of laboratory safety in FDA, CDC, and NIH, citing previous GA...[ Price : $8.95]
FDA warns two firms in Taiwan and Australia about Quality System violations in their manufacturing of x-ray equipment.[ Price : $8.95]
FDA sends Intercept Pharmaceuticals a complete response letter on its supplemental NDA for Ocaliva (obeticholic acid) seeking to c...[ Price : $8.95]
FDA commissioner Robert Califf tells Friends of Cancer Researchs annual meeting that he is personally disappointed in the election...[ Price : $8.95]
Lilly calls on FDA to reject the Outsourcing Facilities Association nomination of tirzepatide to be on the 503 Bulks List so it ca...